If EPS Growth Is Important To You, Catalyst Pharmaceuticals (NASDAQ:CPRX) Presents An Opportunity
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Source: yahoo.com
Page 2 - Catalyst Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Catalyst Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Catalyst Pharmaceutical Today - Breaking & Trending Today
Zacks Research Analysts Cut Earnings Estimates for Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) – Zacks Research lowered their Q3 2023 earnings estimates for Catalyst Pharmaceuticals in a report issued on Wednesday, August 23rd. Zacks Research analyst A. Chakraborty now forecasts that the biopharmaceutical company will earn ($0.21) per share for the quarter, down from their previous estimate of $0.27. The consensus […]
Source: modernreaders.com
Will Weakness in Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Prove Temporary Given Strong Fundamentals?
With its stock down 17% over the past three months, it is easy to disregard Catalyst Pharmaceuticals (NASDAQ:CPRX). But...
Source: yahoo.com
Catalyst Pharmaceuticals: Expecting Higher FIRDAPSE Revenues In A Year (NASDAQ:CPRX)
Catalyst Pharmaceuticals expects its 2Q, 3Q, and 4Q 2023 revenues to be higher than in 1Q. Read more to see why CPRX stock is a Strong Buy.
Source: seekingalpha.com
Catalyst Pharmaceutical (CPRX) Gains As Market Dips: What You Should Know
Catalyst Pharmaceutical (CPRX) closed at $13.15 in the latest trading session, marking a +0.15% move from the prior day.
Source: yahoo.com